Acotiamide Hydrochloride Trihydrate

Acotiamide Hydrochloride Hydrate acts as an acetylcholinesterase inhibitor. It is pending approval in the United States; ten clinical trials have been successfully completed. It is a drug manufactured and approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. . Reference standards of Acotiamide Hydrochloride Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

No Data Found